Suppr超能文献

"Magic Bullets" at the center stage of immune therapy: a special issue on therapeutic antibodies.

作者信息

An Zhiqiang

机构信息

The Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.

出版信息

Protein Cell. 2018 Jan;9(1):1-2. doi: 10.1007/s13238-017-0488-1.

Abstract
摘要

相似文献

1
2
Immunology. Considering therapeutic antibodies.
Science. 2006 Jul 21;313(5785):308-9. doi: 10.1126/science.1130482.
3
Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
Hum Antibodies. 2013;22(1-2):9-13. doi: 10.3233/HAB-130266.
4
[Antibodies--the "magic bullets"?].
Pharm Unserer Zeit. 2006;35(1):84-5. doi: 10.1002/pauz.200690017.
5
Therapeutic antibodies: magic bullets hit the target.
Nature. 2002 Jun 6;417(6889):584-6. doi: 10.1038/417584a.
6
Antitumor Antibodies Can Drive Therapeutic T Cell Responses.
Trends Cancer. 2017 Sep;3(9):615-620. doi: 10.1016/j.trecan.2017.07.001. Epub 2017 Jul 29.
8
Molecular engineering and design of therapeutic antibodies.
Curr Opin Immunol. 2008 Aug;20(4):460-70. doi: 10.1016/j.coi.2008.06.012.
9
From "magic bullets" to specific cancer immunotherapy.
Swiss Med Wkly. 2013 Jan 23;143:w13734. doi: 10.4414/smw.2013.13734. eCollection 2013.
10
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.
Nat Rev Clin Oncol. 2016 May;13(5):273-90. doi: 10.1038/nrclinonc.2016.25. Epub 2016 Mar 15.

引用本文的文献

1
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications.
Signal Transduct Target Ther. 2024 Nov 14;9(1):322. doi: 10.1038/s41392-024-02002-z.
3
Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma.
Aging (Albany NY). 2022 Aug 12;14(15):6299-6315. doi: 10.18632/aging.204221.

本文引用的文献

1
IgG Fc engineering to modulate antibody effector functions.
Protein Cell. 2018 Jan;9(1):63-73. doi: 10.1007/s13238-017-0473-8. Epub 2017 Oct 6.
2
Current progress in innovative engineered antibodies.
Protein Cell. 2018 Jan;9(1):86-120. doi: 10.1007/s13238-017-0457-8. Epub 2017 Aug 18.
3
Molecular and functional analysis of monoclonal antibodies in support of biologics development.
Protein Cell. 2018 Jan;9(1):74-85. doi: 10.1007/s13238-017-0447-x. Epub 2017 Jul 21.
5
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy.
Protein Cell. 2018 Jan;9(1):47-62. doi: 10.1007/s13238-017-0433-3. Epub 2017 Jun 8.
6
Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig.
Protein Cell. 2018 Jan;9(1):121-129. doi: 10.1007/s13238-017-0429-z. Epub 2017 Jun 5.
7
Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab.
Protein Cell. 2018 Jan;9(1):135-139. doi: 10.1007/s13238-017-0412-8.
8
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins.
Protein Cell. 2018 Jan;9(1):15-32. doi: 10.1007/s13238-017-0408-4. Epub 2017 Apr 19.
9
In vitro-engineered non-antibody protein therapeutics.
Protein Cell. 2018 Jan;9(1):3-14. doi: 10.1007/s13238-017-0386-6. Epub 2017 Mar 7.
10
Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
Protein Cell. 2018 Jan;9(1):33-46. doi: 10.1007/s13238-016-0323-0. Epub 2016 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验